BioSpace News Archive

This new collaboration combines expertise from Menicon Co., Ltd., a world-class manufacturer of innovative contact lenses with the science, scale and capabilities of Johnson & Johnson Vision

RestoraFIBRE Daily Gummies contains inulin, a prebiotic fibre which helps support a healthy digestive system and promote regularity

G1 Therapeutics, Inc., a commercial-stage oncology company, announced that G1’s Chief Executive Officer Jack Bailey will participate in the 20th Annual Needham Virtual Healthcare Conference.

BioCryst Pharmaceuticals, Inc. announced that the company will present at the 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021 at 8:45 a.m. ET.

Tonix Pharmaceuticals Holding Corp. a clinical-stage biopharmaceutical company, announced that Seth Lederman, M.D., President and Chief Executive Officer of Tonix Pharmaceuticals, will present a company overview during the 20th Annual Needham Virtual Healthcare Conference on Wednesday, April 14, 2021 at 8:00 a.m. ET.

Kamada Ltd., a plasma-derived biopharmaceutical company, announced an amendment to the GLASSIA® [Alpha1-Proteinase Inhibitor ] license agreement with Takeda.

Skylight Health signs partnership with ClinEdge to bring clinical research to primary care practices in Massachusetts ClinEdge has over ten years experience partnering prominent research sponsors with clinical research sites; Skylight Health provides primary care services in multiple states across the US, and will act as a clinical research site partner for ClinEdge;

Alkermes plc announced that it has entered into a clinical trial collaboration and supply agreement with MSD for a planned phase 3 study to evaluate nemvaleukin alfa, Alkermes’ novel investigational engineered interleukin-2 variant immunotherapy, in combination with MSD’s KEYTRUDA®, in comparison to investigator choice chemotherapy in patients with platinum-resistant ovarian cancer.

Bausch Health Companies Inc. announced it will reduce debt by $100 million through the redemption of outstanding senior secured notes, using cash generated from operations.

CTI BioPharma Corp. (NASDAQ: CTIC) today announced that management will provide a corporate overview at the 20th Annual Needham Virtual Healthcare Conference at 3:00 p.m. EST .